Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Use of OCs Containing Dienogest and Risk of Venous Thromboembolism.

Trial Profile

Use of OCs Containing Dienogest and Risk of Venous Thromboembolism.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Mar 2010

At a glance

  • Drugs Dienogest (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Dec 2009 Actual number of patients changed from 681 to 3400 as reported by ClinicalTrials.gov.
    • 05 Feb 2009 Actual number of patients added (681) as reported by ClinicalTrials.gov.
    • 05 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top